CV/COS Webinar: Clip 11

At Carevive, our primary goal is to ensure that the quality of life data we collect is not only relevant but also actionable for both care teams and patients. Our platform provides temporal summaries of the patient experience and utilizes alert triggers to respond to severe symptoms, enabling care teams to promptly reach out, manage symptoms, and document care.

Numerous studies, including our own data, have shown that integrating patient-reported outcomes (PROs) into the workflow leads to improved patient adherence to therapy and reduced hospitalizations and emergency room visits.

This unique workflow allows us to generate what we call “smart data” – a powerful combination of structured elements from electronic medical records (EMRs) paired with validated PRO data. The integration of these datasets empowers care teams with a comprehensive view of patient health, enabling personalized and effective cancer care.

Recent Episodes

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…